Rotavirus is a segmented double-stranded (ds)RNA virus that causes severe gastroenteritis in 23 young children. We have established an efficient simplified rotavirus reverse genetics (RG) 24 system that uses eleven T7 plasmids, each expressing a unique simian SA11 (+)RNA, and a 25 CMV support plasmid for the African swine fever virus NP868R capping enzyme. With the 26 NP868R-based system, we generated recombinant rotavirus (rSA11/NSP3-FL-UnaG) with a 27 genetically modified 1.5-kB segment 7 dsRNA that encodes full-length NSP3 fused to UnaG, a 28 139-aa green fluorescent protein (FP). Analysis of rSA11/NSP3-FL-UnaG showed that the virus 29 replicated efficiently and was genetically stable over 10 rounds of serial passage. The NSP3-30
Notably, Komoto et al (2018) showed that recombinant virus could be produced simply by 81 transfecting BHK-T7 cells with eleven SA11 T7 plasmids, with the caveat that plasmids for the 82 viroplasm building blocks (NSP2 and NSP5) (Fabbretti et al., 1999; Eichwald et al., 2004) be 83 added at levels three-fold greater than the other plasmids. Of possible significance, the Komoto 84 RG system used a set of SA11 T7 plasmids with vector backbones that differed in size and 85 sequence from the SA11 T7 plasmids described by Kanai et al (2017) . In this study, we explored an alternative approach for making FP-RVAs, one relying on 99 modification of the genome segment that expresses NSP3 (segment 7), a viral translation 100 enhancer expressed at moderate levels in the infected cell that may not be required for virus 101 replication (Montero et al., 2006; Gratia et al., 2015) . In generating recombinant RVAs, we 102 employed a simplified RG system requiring only a single support plasmid: a CMV expression 103 vector for the African swine fever virus (ASFV) NP868R capping enzyme (Dixon et al., 2013) . 104 pT7/NSP1SA11. For cloning, the pT7/NSP1SA11 plasmid was amplified using the NSP1 primer 139 pair 5'-tgaagaagtgtttaatcacatgtcgcc-3' and 5'-tttgatccatgtgattagtaaacaaactccaaa-3 and the 3xFL-140
UnaG insert was amplified from pT7/NSP3-R2A-FL-UnaG using the primer pair 5'-141 tcacatggatcaaacctacaaagaccatgacggtgattataaagatcat-3' and 5'-142 ttaaacacttcttcatcattctgtggcccttctgtagc-3'. Transfection quality plasmids were prepared 143 commercially (www.plasmid.com) or using a QIAprep spin miniprep kit. Primers and 144 sequencing services were provided by Eurofin Genomics. Sequences of recombinant RVAs were 145 determined from cDNAs prepared from viral RNAs using a Superscript III reverse transcriptase 146 kit (Invitrogen). 147
Optimized RVA RG protocol. On Day 0, freshly confluent monolayers of BHK-T7 cells 148 were disrupted using trypsin-versene and resuspended in G418-free Glasgow complete medium 149 containing 5% FBS. Cell numbers were determined with a Nexcelom Cellometer AutoT4 150 counter. The cells were seeded in the same medium into 12-well plates (2-4 x 105 cells/well). On 151 Day 1, plasmid mixtures were prepared that contained 0.8 g each of the 11 RVA pT7 plasmids, 152 except pT7/NSP2SA11 and pT7/NSP5SA11, which were 2.4 g each. Included in plasmid 153 mixtures was 0.8 g of pCMV/NP868R. The plasmid mixtures were added to 100 l of pre-154 warmed (37C) Opti-MEM (Gibco) and mixed by gently pipetting up and down. Afterwards, 25 155 l of TransIT-LTI transfection reagent (Mirus) was added, and the transfection mixtures gently 156 vortexed and incubated at room temperature for 20 min. During the incubation period, BHK-T7 157 cells in 12-well plates were washed once with Glasgow complete medium, and then 1 ml of 158 SMEM complete medium [MEM Eagle Joklik (Lonza), 10% TBP, 2% NEAA, 1% P/S, and 1% 159 glutamine)] was placed in each well. The transfection mixture was added drop-by-drop to the 160 medium in the wells and the plates returned to a 37C incubator. On Day 3, 2 x105 MA104 cells 161 in 250 l of M199 complete medium were added to wells, along with trypsin to a final 162 concentration of 0.5 g/ml (porcine pancreatic type IX, Sigma Aldrich). On Day 5, cells in plates 163 were freeze-thawed 3-times and the lysates placed in 1.5 ml microfuge tubes. After 164 centrifugation at 500 x g for 10 min (4C), 300 l of the supernatant was transferred onto 165 MA104 monolayers in 6-well plates containing 2 ml of M199 complete medium and 0.5 g/ml 166 trypsin. The plates were incubated at 37C for 7 days or until complete cytopathic effects (CPE) 167 were observed. Typically, complete CPE was noted at 4-6 days p.i. for wells containing 168 replicating RVA. 169
Analysis of recombinant viruses. RVAs were propagated in MA104 cells in M199 170
complete medium containing 0.5 g/ml trypsin. Viruses were isolated by plaque purification and 171 titered by plaque assay or fluorescence focus assay on MA104 cells (Arnold et al., 2009 Signaling Technology (CST), 1:1000) antibody. Primary antibodies were detected using 184 1:10,000 dilutions of horseradish peroxidase (HRP)-conjugated secondary antibodies: horse anti-185 mouse IgG (CST), anti-guinea pig IgG (KPL), or goat anti-rabbit IgG (CST). Signals were 186 developed using Clarity Western ECL Substrate (Bio-Rad) and detected using a Bio-Rad 187
ChemiDoc imaging system. Image J analysis was used to determine the intensity of bands on 188 immunoblots {https://imagej.net/ImageJ}. 189
Assessment of genetic stability. MA104 cell monolayers in 6-well plates were infected 190 with recombinant RVA at an MOI of ~0.1. When cytopathic effects were complete (4-5 days 191 p.i.), the cells were freeze-thawed twice in their medium, and lysates were centrifuged at low 192 speed to remove debris. Virus in clarified lysates was serially passaged 10-times, infecting 193 MA104 cells with 2 l of lysate combined with 2 ml of fresh M199 complete medium. To 194 analyze viral dsRNA content, 0.6 ml of clarified lysates were incubated with 1 l of RNase T1 195 (Fermentas, 1000 U/ml) for 30 min at 37C, extracted with Trizol, and pelleted by ethanol 196 precipitation. Purified dsRNA was resolved by electrophoresis on 8% polyacrylamide gels and 197 detected by staining with ethidium bromide. Plaque purification was used to recover six virus 198 isolates from the passage 10 pool of rSA11/NSP3-FL-UnaG. The segment 6 (VP6) and 7 (NSP3) 199
RNAs of three isolates were sequenced by Eurofins Genomics. Rotavirus RG experiments were performed using stocks of BHK-T7 cells maintained in 242
Glasgow medium enriched with FBS, tryptone-peptide broth, and non-essential amino acids. 243
Mixtures of RG plasmids were transfected into BHK-T7 cells that were ~90% confluent and had 244 been seeded into 12-well plates the day before. In our optimized protocol, plasmid mixtures 245 included pCMV/NP868R, 3x levels of pT7/NSP2SA11 and pT7/NSP5SA11, either 246 pT7/NSP3SA11 or pT7/NSP3-FL-UnaG, and the remaining SA11 pT7 plasmids. Transfected 247 BHK-T7 cells were over seeded with MA104 cells to promote amplification of recombinant 248 viruses. At 5 days post transfection, the cells were freeze-thawed thrice and large debris removed 249 by low speed centrifugation. Recombinant viruses in cell lysates were amplified by passage in 250 MA104 cells, plaque isolated, and amplified again in MA104 cells. 251
Recombinant SA11 expressing fused NSP3-UnaG. Analysis of the cell lysates showed 252 that transfection of BHK-T7 cells with RG plasmid mixtures using the optimized protocol 253 supported the generation of recombinant RVAs, including SA11 isolates with a wildtype 254 segment 7 (NSP3) dsRNA (rSA11/wt) or a modified segment 7 RNA (rSA11/NSP3-FL-UnaG) 255 ( Fig. 2) . The identity of the modified segment 7 dsRNA in rSA11/NSP3-FL-UnaG was verified 256 by gel electrophoresis ( Fig. 2A ), which revealed that the wildtype 1-kB segment 7 dsRNA had 257 been replaced with a segment co-migrating with the 1.5-kB segment 5 (NSP1) dsRNA. The 258 authenticity of the segment 7 dsRNA in rSA11/NSP3-FL-UnaG was confirmed by RT-PCR and 259 sequencing (data not shown). Immunoblot analysis with anti-NSP3 and anti-FLAG antibodies of 260 infected cell lysates indicated that segment 7 of rSA11/NSP3-FL-UnaG expressed a protein of 261 the expected size (55 kD) for NSP3-FL-UnaG and did not express the wildtype 37-kD NSP3 262 ( Fig. 2B ). As a probe of the properties of NSP3-FL-UnaG, we examined whether the protein was 263 able to form dimers in infected cells, as previously reported for wildtype NSP3 (Arnold et al, 264 2012). Indeed, electrophoretic analysis of rSA11/NSP3-UnaG-infected cell lysates treated with 265 denaturing sample buffer at 25oC showed that the NSP3-FL-UnaG migrated as a dimer (Fig. 3) , 266 suggesting that the NSP3 coiled-coil dimerization domain retains its function in the fusion 267 product. Under these same electrophoretic conditions, the VP6 inner capsid protein of both 268 rSA11/NSP3-FL-UnaG and rSA11/wt formed trimers that were stable at 25oC ( Plaque analysis showed that rSA11/wt grew to a peak titer in MA104 cells that was ~2-3-275 fold greater than rSA11/NSP3-FL-UnaG (1.6 -4.8 x 107 and 0.6 -2.0 x 107, respectively) and 276 generated plaques that were ~2-fold larger (Fig. 4 ). Ten rounds of serial passage of rSA11/NSP3-277 FL-UnaG at low MOI revealed no difference in the dsRNA profile of the starting virus and the 278 passage 10 virus, suggesting that the recombinant RVA was genetically stable (Fig. 5 ). To 279 further evaluate this issue, the segment 6 (VP6) and 7 (NSP3) RNAs of three plaque isolates 280 recovered from the passage 10 pool of rSA11/NSP3-FL-UnaG were sequenced. The sequences 281 of segment 6 and 7 RNAs were the same as those present in the pT7/VP6SA11 and pT7/NSP3-282 FL-UnaG plasmids used to make the recombinant viruses. Thus, based on serial passage and 283 sequencing of P10 viruses, rSA11/NSP3-FL-UnaG appears to stably retain its foreign sequence. 284 readily detected in the nucleus (Move S1). To contrast the intensity of the fluorescent signal 290 produced by recombinant viruses expressing UnaG fused to NSP3 versus NSP1, we generated 291 rSA11/NSP1-FL-UnaG (Fig. 7) using the optimized NP868R-based RG protocol. To produce 292 this virus, a FL-UnaG ORF terminating with a stop codon was inserted into NSP1 ORF of the 293 segment 5 cDNA of pT7/NSP1SA11. As illustrated in Fig. 7 , pT7/NSP1-FL-UnaG produces a 294 2.1-kb RNA that encodes a 575-aa protein instead of the 1.6-kb RNA and 520-aa protein of 295 pT7/NSP1SA11. The segment-5 protein product of pT7/NSP1-FL-UnaG ends with the same 296
Flag-UnaG cassette as the segment-7 protein product of pT7/NSP3-FL-UnaG. 297
As determined by gel electrophoresis (Fig. 7) and sequencing (not shown), the genome of 298 rSA11/NSP1-FL-UnaG included the expected large 2.1-kB segment 5 dsRNA. Immunoblot 299 analysis of rSA11/NSP1-FL-UnaG-infected cell lysates using anti-Flag antibody indicated that 300 the virus also encoded the NSP1-FL-UnaG product. Based on plaque assay, rSA11/NSP1-FL-301
UnaG grew to a peak titer (0.8 -1.0 x 107) that was ~3-fold less than rSA11/wt and produced 302 plaques on MA104 cells that were ~2-fold smaller than rSA11/wt ( Fig. 4 ) The small plaque 303 phenotype of rSA11/NSP1-FL-NSP1 is similar to small plaque phenotype described before for 304
RVAs encoding truncated or altered NSP1 proteins (Patton et al., 2001) . 305
Quantification of UnaG fluorescence signals generated by MA104 cells infected with 306 rSA11/NSP3-FL-UnaG were approximately 3-times greater than those generated by cells 307 infected with rSA11/NSP1-FL-UnaG (Fig. 6B ). This result suggests that RVAs expressing fused 308 NSP3-FPs may be more sensitive probes of viral infection that RVAs expressing fused NSP1-309
FPs. 310
Stem-loop structure in the segment 7 3'-UTR. rSA11/NSP3-FL-UnaG was generated by 311 placing a nonviral 500-bp insert into the segment 7 dsRNA at the junction of the NSP3 ORF and 312 an identical stem-loop structure projecting from the 5' side of the 5'-3 panhandle, formed by 332 residues that are highly conserved among RVA segment 8 RNAs. The conservation of the 333 structure and its sequence suggested that the stem-loop may function as a segment specific 334 packaging signal (Navarro et al., 2013). We performed a similar in silico RNA folding analysis, 335 contrasting the secondary structures predicted for the segment 7 RNAs of rSA11/wt and 336 rSA11/NSP3-FL-UnaG. The results showed that the overall secondary structures predicted for 337 the RNAs differed considerably, with the notable exception that extending from the 3'-UTR of 338 both RNAs was a long (~70 base) stable stem-loop structure formed by sequences that are highly 339 conserved in RVA segment 7 RNAs (Fig. 8) . The stability and location of the stem-loop suggests 340 that this structure may function as a segment specific packaging signal, in a manner previously 341 proposed for the conserved stem-loop detected in the segment 8 RNA. Figure 3 . Dimerization of NSP3-FL-UnaG. MA104 cells were mock infected, or infected with rSA11/wt or rSA11/NSP3-FL-UnaG and incubated until 8 h p.i., when cells were harvested. Cell lysates were mixed with sample buffer containing sodium dodecyl sulfate and b-mercaptoethanol, incubated for 10 min either at 25 or 95 o C, resolved by electrophoresis on a Novex 8-16% polyacrylamide gel, and the blotted onto a nitrocellulose membrane. Blots were probed with guinea pig polyclonal anti-NSP3 or anti-VP6 antibodies, or with a mouse anti-PCNA monoclonal antibody. Primary antibodies were detected using horseradish peroxidase-conjugated secondary antibodies. Sizes (kD) of protein markers (M) are indicated. NSP3 band intensities were determined by Image J analysis and were normalized to VP6 band intensities. , 1994) . Portions of the secondary structures are shown that include the 5' and 3' ends of the (+)RNAs (labeled) and the conserved 3' stem-loops (3'SL) (boxed). Also labeled are the start and stop codons (green and red arrowheads, respectively) of both the NSP3 and NSP3-FL-UnaG ORFs. 
